Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $17M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 7 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -5%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 7 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $39M covers the $2M due within a year 25.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2022-09-30 (10-Q).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~22.1% on $23M of debt.
Cash of $39M fully covers short-term debt of $1M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $251.7M 100.0% | $418.8M 100.0% | $527.1M 100.0% | $692.2M 100.0% | $873.6M 100.0% | $863.6M 100.0% | $755.8M 100.0% |
| Cost of Revenue | $67.9M 27.0% | $131.5M 31.4% | $204.0M 38.7% | $322.6M 46.6% | $328.7M 37.6% | $249.7M 28.9% | $210.3M 27.8% |
| Gross Profit | $183.8M 73.0% | $287.3M 68.6% | $323.1M 61.3% | $369.6M 53.4% | $545.0M 62.4% | $613.9M 71.1% | $545.5M 72.2% |
| Research & Development | $1.7M 0.7% | $1.6M 0.4% | $2.7M 0.5% | $4.4M 0.6% | $4.6M 0.5% | $4.6M 0.5% | $4.6M 0.6% |
| Selling, General & Admin | $39.9M 15.9% | $49.2M 11.7% | $57.9M 11.0% | $78.4M 11.3% | $79.7M 9.1% | $64.8M 7.5% | $56.9M 7.5% |
| Total Operating Expenses | $178.3M 70.8% | $353.6M 84.4% | $464.1M 88.0% | $572.7M 82.7% | $842.3M 96.4% | $620.2M 71.8% | $526.6M 69.7% |
| Operating Income | $5.5M 2.2% | -$66.2M -15.8% | -$141.0M -26.7% | -$203.2M -29.3% | -$297.3M -34.0% | -$6.3M -0.7% | $18.9M 2.5% |
| Interest Expense | $5.0M 2.0% | $6.9M 1.6% | $8.9M 1.7% | $3.4M 0.5% | $536K 0.1% | $527K 0.1% | $790K 0.1% |
| Interest & Investment Income | $1.1M 0.4% | $1.2M 0.3% | $1.9M 0.4% | — | — | — | — |
| Other Income (Expense), net | $859K 0.3% | $2.9M 0.7% | $1.7M 0.3% | $958K 0.1% | $3.2M 0.4% | $666K 0.1% | $813K 0.1% |
| Pretax Income | -$2.7M -1.1% | -$71.4M -17.0% | -$152.6M -29.0% | -$197.2M -28.5% | -$243.9M -27.9% | -$6.2M -0.7% | $18.9M 2.5% |
| Income Tax Expense | $125K 0.0% | $239K 0.1% | $37K 0.0% | -$3.1M -0.4% | -$15.5M -1.8% | $15.3M 1.8% | -$13.4M -1.8% |
| Net Income | -$2.9M -1.1% | -$71.6M -17.1% | -$152.6M -29.0% | -$194.2M -28.1% | -$228.4M -26.1% | -$21.4M -2.5% | $32.3M 4.3% |
| Per Share | |||||||
| EPS (Basic) | $-0.41 | $-10.51 | $-24.47 | $-31.58 | $-0.83 | $-0.09 | $0.14 |
| EPS (Diluted) | $-0.41 | $-10.51 | $-24.47 | $-31.58 | $-0.83 | $-0.09 | $0.12 |
| Weighted Avg Shares (Basic) | 7.0M | 6.8M | 6.2M | 6.1M | 275.4M | 239.5M | 236.3M |
| Weighted Avg Shares (Diluted) | 7.0M | 6.8M | 6.2M | 6.1M | 275.4M | 239.5M | 276.1M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
No current price collected.
Nothing notable to watch.
Where each multiple sits in its own 5-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 5-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 2.7× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Cost of Revenue | 27.8 | 28.9 | 37.6 | 46.6 | 38.7 | 31.4 | 27.0 |
| Gross Profit | 72.2 | 71.1 | 62.4 | 53.4 | 61.3 | 68.6 | 73.0 |
| R&D | 0.6 | 0.5 | 0.5 | 0.6 | 0.5 | 0.4 | 0.7 |
| SG&A | 7.5 | 7.5 | 9.1 | 11.3 | 11.0 | 11.7 | 15.9 |
| Operating Income | 2.5 | -0.7 | -34.0 | -29.3 | -26.7 | -15.8 | 2.2 |
| Income Tax | -1.8 | 1.8 | -1.8 | -0.4 | 0.0 | 0.1 | 0.0 |
| Net Income | 4.3 | -2.5 | -26.1 | -28.1 | -29.0 | -17.1 | -1.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on BODI: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.